The Utilization Pattern and Costs Analysis of Psychotropic Drugs at a Neuropsychiatric Hospital in Nigeria
Charles C. Ezenduka, Vincent N. Ubochi, Brian O. Ogbonna
Journal of Pharmaceutical Research International · pp. 325–337 · Published 25 Nov 2013
10.9734/BJPR/2014/5988Abstract
Background/Aim: Drug utilisation study is essential for evaluating patient care to improve service delivery through awareness creation for appropriate choice of drugs. The study analysed the prescription pattern and associated costs of psychotropic drugs at the outpatient unit of a mental health facility in Nigeria, to assess and document information for enhancing rational and cost-effective use of psychotropic medicines. Methods: A retrospective analysis of prescription records covering 8 September and 28 October 2008, was carried out using the WHO recommended use indicators, adapted for mental health care. Data was analysed for number of drugs, number of prescriptions, cost of prescription and cost per defined daily dose (DDD). Results: 1,756 prescriptions were analysed. Each prescription contained an average of 2.1 (±0.75) drugs, at a mean cost of N1, 089 (±N2, 127). Antipsychotics accounted for the highest number of prescribed drugs in 82% (1441/1756) of prescriptions, followed by antidepressants, 13%. Atypical antipsychotics were the most expensive psychotropics at an average cost per DDD of N241.67 (±N97.77), about 35 times the average cost per DDD of traditional psychotropics at N7.00 (±N2.65), which were the cheapest, accounting for over 90% of total prescriptions. Conclusion: The high use frequency of antipsychotics suggests psychosis as the prevalent mental health disorders in the environment. Significant antipsychotic-antipsychotic combinations indicate scope for improving the use of antipsychotics. Average cost of prescription reflects the economic status of patients’ population where cost appears to be the major consideration of the choice of prescribers, limiting the use of newer and better tolerated psychotropics. Policy measures are required to improve access to the utilisation of newer psychotropics for enhanced quality of life of patients. The study provides a baseline data for carrying out further utilisation studies, to provide regular information for improving psychotropic drugs utilisation in mental health facilities in Nigeria.
Cited by 10
UdayVenkat Mateti, Pramitha Prabhakaran, TS Sanal · Asia Pacific Journal of Clinical Trials: Nervous System Diseases · 2016
· International Journal of Pharmacy and Infections Therapy · 2021
Joseph O. Fadare, Okezie O. Enwere, Adekunle O. Adeoti · Value in Health Regional Issues · 2020
Olayinka O. Ogunleye, Joseph O. Fadare, Adesola F. Yinka-Ogunleye · Hospital Practice · 2018
Onyinye Onyeka Akunne, Brian Godman, Aduragbenro Deborah Adedapo · Journal of Comparative Effectiveness Research · 2016
Brian Godman, Christoffel Grobler, Marianne Van-De-Lisle · Expert Opinion on Pharmacotherapy · 2019
Tanveer Ahmed Khan, Shahzad Hussain, Aamer Ikram · Hospital Practice · 2020
Oyinlade A. Kehinde, Emmanuel N. Anyika, Isaac Abah · Journal of Hospital Administration · 2017
Joseph O Fadare, Adekunle O. Adeoti, Olufemi O. Desalu · Expert Review of Pharmacoeconomics & Outcomes Research · 2015
Sidra Mahmood, Shahzad Hussain, Taufeeq ur Rehman · Current Medical Research and Opinion · 2018
Related research
- First Trimester Fasting Blood Glucose as a Screening Tool for Diabetes Mellitus in a Teaching Hospital Setting in Nigeria — shares topic coverage
- The Nature and Complications of Acute Traumatic Cervical Spinal Cord Injury in a University Hospital in Nigeria — shares topic coverage
- Musculoskeletal Complications of Sickle Cell Anaemia and Their Management Approaches in Makurdi, Nigeria — shares topic coverage
- Work-related Musculoskeletal Disorders among Radiologists in Nigeria — shares topic coverage
- The Skills of Cardiopulmonary Resuscitation in Some Professional and Student Teachers Compared — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
10
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.